References

kpccz

Комплексные проблемы сердечно-сосудистых заболеваний

Complex Issues of Cardiovascular Diseases

2306-12782587-9537

Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”

10.17802/2306-1278-2016-1-12-17

kpccz-170

Research Article

АКТУАЛЬНЫЕ ВОПРОСЫ БИОЛОГИЧЕСКОГО ПРОТЕЗИРОВАНИЯ СТРУКТУР СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ

ИНФЕКЦИЯ СОСУДИСТЫХ ПРОТЕЗОВ

Infection of vascular grafts

АБДУЛГАСАНОВ

Р. А.

ABDULGASANOV

R. A.

117931, Москва, Ленинский проспект, д. 8, к. 7. Тел: 8-926-303-07-51

Apt. 7, 8, Leninskiy prospect, Moscow, 117931, Russian Federation Tel. +7-926-303-07-51

ramizsurgeon@mail.ru

Федеральное государственное бюджетное учреждение «Научный центр сердечно-сосудистой хирургии им. А. Н. Бакулева» Российской академии наук, Москва, РоссияРоссияFederal State Budgetary Institution Bakoulev Scientific Centre for Cardiovascular Surgery Russian Academy of Sciences, Moscow, RussiaRussian Federation

2016

04052016

011217

2016

АБДУЛГАСАНОВ Р.А.

ABDULGASANOV R.A.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.nii-kpssz.com/jour/article/view/170

Описаны различные варианты хирургической тактики при протезной инфекции (ПИ) сосудов. Приведены основные виды хирургической тактики, такие как: экстраанатомическое шунтирование, использование искусственных протезов, применение аллографтов и бедренной вены. Указаны достоинства и недостатки каждого метода. Проведен сравнительный анализ используемых методик. Определены показания и противопоказания для каждого способа. Описаны ситуации, в которых возможно предпринять попытку консервативного ведения ПИ, а также применения искусственных протезов для репротезирования. Подробно изложены возможные пути предотвращения ПИ. Описаны различные подходы к антибиотикопрофилактике нагноений сосудистых протезов. Приведено поэтапное развитие методов профилактики инфекционных осложнений со стороны искусственного протеза.

Different variants of surgical tactics at suppuration of the vascular prosthesis are described in the review. Basic variants of surgical tactics such as extraanatomic bypass, vascular prosthesis regrafting, appliance of allograft and femoral vein are proposed. Pros and cons of each method are shown. Comparative analysis of the performed techniques was performed. Indications and contraindications for each method are determined. Situations suitable for attempt of conservative treatment of infected prosthesis and regrafting by vascular prosthesis are described. Possible ways of prevention of the vascular prosthesis contamination are described in details. Different approaches to the antibiotics prevention of the infectious complications are listed. Step-by-step development of the prevention methods of the infectious complications is carried out.

искусственный протезинфекция протезаэкстраанатомическое шунтированиеаллографт

artificial prosthesisprosthesis infectionextraanatomic bypassallograft

References1

Hasse B., Husmann L., Zinkernagel A., Weber R., Lachat M., Mayer D. Vascular graft infections. Swiss. Med. Wkly. 2013; 24; 143: 13754.

Darouiche R. O. Treatment of infections associated with surgical implants. N. Engl. J. Med. 2004; 350: 1422–1429.

Saleem B. R., Meerwaldt R., Tielliu I. F., Verhoeven E. L., van den Dungen J. J., Zeebregts C. J. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am. J. Surg. 2010; 200 (1): 47‒52.

Calligaro K. D., Veith F. J., Yuan J. G., Gargiulo N. J., Dougherty M. J. Intra-abdominal aortic graft infection: complete or partial graft preservation in patients at very high risk. J. Vasc. Surg. 2003; 38: 1199–1205.

Bandyk D. F. Vascular surgical site infection: risk factors and preventive measures. Semin. Vasc. Surg. 2008; 21: 119–123.

Swain T. W. 3rd, Calligaro K. D., Dougherty M. D. Management of infected aortic prosthetic grafts. Vasc. Endovascular Surg. 2004; 38: 75–82.

Antonios V. S., Noel A. A., Steckelberg J. M., Wilson W. R., Mandrekar J. N., Harmsen W. S. et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J. Infect. 2006; 53: 49–55.

Turtiainen J., Saimanen E., Partio T., Karkkainen J., Kiviniemi V., Makinen K. et al. Surgical wound infections after vascular surgery: prospective multicenter observational study. Scand. J. Surg. 2010; 99: 167–172.

Nagpal A., Sohail M. R. Prosthetic vascular graft infections: a contemporary approach to diagnosis and management.Curr. Infect. Dis. Rep. 2011; 13: 317–323.

Seeger J. M. Management of patients with prosthetic vascular graft infection. Am. Surg. 2000; 66: 166–177.

Stone P. A., Back M. R., Armstrong P. A., Brumberg R. S., Flaherty S. K., Johnson B. L. et al. Evolving microbiology and treatment of extracavitary prosthetic graft infections. Vasc. Endovascular Surg. 2008; 42: 537–544.

Mayer D., Hasse B., Koelliker J., Enzler M., Veith F. J., Rancic Z. et al. Long-term results of vascular graft and artery preserving treatment with negative pressure wound therapy in Szilágyi grade III infections justify a paradigm shift. Ann. Surg. 2011; 254: 754–759.

Fitzgerald S. F., Kelly C., Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J. Antimicrob. Chemother. 2005; 56: 996–999.

Szilagyi D. E., Smith R. F., Elliott J. P., Vrandecic M. P. Infection in arterial reconstruction with synthetic grafts. Ann. Surg. 1972; 176: 321–333.

Samson R. H., Veith F. J., Janko G. S., Gupta S. K., Scher L. A. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J. Vasc. Surg. 1988; 8: 147–153.

Low R. N., Wall S. D., Jeffrey R. B. Jr., Sollitto R. A., Reilly L. M., Tierney L. M. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology. 1990; 175: 157–162.

Mark A., Moss A. A., Lusby R., Kaiser J. A. CT evaluation of complications of abdominal aortic surgery. Radiology. 1982; 145: 409–414.

Fiorani P., Speziale F., Rizzo L., De Santis F., Massimi G. J., Taurino M. et al. Detection of aortic graft infection with leukocytes labeled with technetium 99m-hexametazime. J. Vasc. Surg. 1993; 17: 87–95.

Stumpe K. D., Dazzi H., Schaffner A., von Schulthess G. K. Infection imaging using whole-body FDG-PET. Eur. J. Nucl. Med. 2000; 27: 822–832.

von Schulthess G. K., Meier N., Stumpe K. D. Joint accumulations of FDG in whole body PET scans. Nuklearmedizin. 2001; 40: 193–197.

Fukuchi K., Ishida Y., Higashi M., Tsunekawa T., Ogino H., Minatoya K. et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J. Vasc. Surg. 2005; 42: 919–925.

Keidar Z., Engel A., Hoffman A., Israel O., Nitecki S. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. J. Nucl. Med. 2007; 48: 1230–1236.

Bruggink J. L., Glaudemans A. W., Saleem B. R., Meerwaldt R., Alkefaji H., Prins T. R. et al. Accuracy of FDG-PETCT in the diagnostic work-up of vascular prosthetic graft infection. Eur. J. Vasc. Endovasc. Surg. 2010; 40: 348–354.

Stadler P., Bilohlavek O., Spacek M., Michalek P. Diagnosis of vascular prosthesis infection with FDG-PET/CT. J. Vasc. Surg. 2004; 40: 1246–1247.

Spacek M., Belohlavek O., Votrubova J., Sebesta P., Stadler P. Diagnostics of “non-acute” vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur. J. Nucl. Med. Mol. Imaging. 2009; 36: 850–858.

Coselli J. S., Koksoy C., LeMaire S. A. Management of thoracic aortic graft infections. Ann. Thorac. Surg. 1999; 67:1990–2993; 1997–1998.

Roy D., Grove D. I. Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts. J. Infect. 2000; 40: 184–204.

Baddour L. M. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am. J. Med. Sci. 2001; 322: 209–212.

Cherry K. J. Jr., Roland C. F., Pairolero P. C., Hallett J. W. Jr., Meland N. B., Naessens J. M. et al. Infected femorodistal bypass: is graft removal mandatory? J. Vasc. Surg. 1992; 15: 295–303; 303–295.

Gutowski P. Aortoiliac graft infection as a diagnostic and treatment problem. Ann. Acad. Med. Stetin. 1998; Suppl. 41: 1–72.

Topel I., Audebert F., Betz T., Steinbauer M. G. Microbial Spectrum and Primary Resistance to Rifampicin in Infectious Complications in Vascular Surgery: Limits to the Use of Rifampicin-Bonded Prosthetic Grafts. Angiology. 2010; 61: 423‒426.

D’Addato M., Curti T., Freyrie A. Prophylaxis of graft infection with rifampicin-bonded Gelseal graft: 2-year followup of a prospective clinical trial. Italian Investigators Group. Cardiovasc. Surg. 1996; 4: 200–204.

Braithwaite B. D., Davies B., Heather B. P., Earnshaw J. J. Early results of a randomized trial of rifampicinbonded Dacron grafts for extra-anatomic vascular reconstruction. Joint Vascular Research Group. Br. J. Surg. 1998; 85:1378–1381.

Earnshaw J. J., Whitman B., Heather B. P. Two-year results of a randomized controlled trial of rifampicin-bonded extra-anatomic dacron grafts. Br. J. Surg. 2000; 87: 758–759.

O’Connor S., Andrew P., Batt M., Becquemin J. P. A systematic review and meta-analysis of treatments for aortic graft infection. J. Vasc. Surg. 2006; 44: 38–45.

Morykwas M. J., Argenta L. C., Shelton-Brown E. I., McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann. Plast. Surg. 1997; 38: 553–562.

Dosluoglu H. H., Loghmanee C., Lall P., Cherr G. S., Harris L. M., Dryjski M. L. Management of early (<30 day) vascular groin infections using vacuum-assisted closure alone without muscle flap coverage in a consecutive patient series. J. Vasc. Surg. 2010; 51: 1160‒1166.

Dosluoglu H. H., Schimpf D. K., Schultz R., Cherr G. S. Preservation of infected and exposed vascular grafts using vacuum assisted closure without muscle flap coverage. J. Vasc. Surg. 2005; 42: 989–992.

Nordmyr J., Svensson S., Bjorck M., Acosta S. Vacuum assisted wound closure in patients with lower extremity arterial disease. The experience from two tertiary referral-centres. Int. Angiol. 2009; 28: 26–31.

Kragsterman B., Bjorck M., Wanhainen A. EndoVAC, a novel hybrid technique to treat infected vascular reconstructions with an endograft and vacuum-assisted wound closure. J. Endovasc. Ther. 2011; 18: 666–673.

BSAC – The British Society for Antimicrobial Chemotherapy. Treatment of hospital infections prosthetic vascular graft infections [Internet]. Available from: http://www.bsac.org.uk.

Legout L., Sarraz-Bournet B., D’Elia P. V., Devos P., Pasquet A., Caillaux M. et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin. Microbiol. Infect. 2012; 18: 352‒356.

Szczot M., Meybeck A., Legout L., Pasquet A., Van Grunderbeeck N., Langlois J. et al. Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J. Infect. 2011; 62: 204–211.

Pounds L. L., Montes-Walters M., Mayhall C. G., Falk P. S., Sanderson E., Hunter G. C. et al. A changing pattern of infection after major vascular reconstructions. Vasc. Endovascular Surg. 2005; 39: 511–517.

Cowie S. E., Ma I., Lee S. K., Smith R. M., Hsiang Y. N. Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome. Vasc. Endovascular Surg. 2005; 39: 327–334.

Kotsis T., Lioupis C. Use of vacuum assisted closure in vascular graft infection confined to the groin. Acta Chir. Belg. 2007; 107: 37–44.

Pinocy J., Albes J. M., Wicke C., Ruck P., Ziemer G. Treatment of periprosthetic soft tissue infection of the groin following vascular surgical procedures by means of a polyvinyl alcohol-vacuum sponge system. Wound Repair Regen. 2003; 11: 104–109.

Ohta T., Hosaka M., Ishibashi H., Sugimoto I., Takeuchi N., Kazui H. et al. Treatment for aortic graft infection. Surg. Today. 2001; 31: 18–26.

The authors declare that there are no conflicts of interest present.